pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,347 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›WITHDRAWNphase readoutNCT04590209: Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Adult Patients With Lesions on Fingers or Toes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07516509: Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

Sponsor: AdventHealth Translational Research Institute. Phase: . Conditions: Insulin Resistance

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07446699: The Effect of Pushing Techniques Used During Childbirth on Women's Labor Duration, Pain, and Fatigue Levels

Sponsor: Cumhuriyet University. Phase: NA. Conditions: Childbirth, Duration of Labor, Labor Pains, Pushing During Childbirth, Fatigue During Childbirth

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583732: BIS in Critically Ill Patients in ICU

Sponsor: Mahidol University. Phase: NA. Conditions: Critically Ill Patients

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07234032: An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Pulmonary Hypertension, Interstitial Lung Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07630532: Virtual Reality Relaxation for Insomnia

Sponsor: Laval University. Phase: NA. Conditions: Insomnia Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT02941263: Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration

Sponsor: National Eye Institute (NEI). Phase: . Conditions: Age-Related Macular Degeneration

full page →ctgov ↗
›RECRUITINGphase readoutNCT07129993: Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Sponsor: Daiichi Sankyo. Phase: PHASE2. Conditions: Urothelial Cancer, Bladder Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06898021: The 3D Stent Study

Sponsor: CoreAalst BV. Phase: . Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention (PCI)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06414993: Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults

Sponsor: Chestnut Health Systems. Phase: NA. Conditions: Polysubstance Drug Use (Indiscriminate Drug Use)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02675114: PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Aortic Stenosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00335816: Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Colorectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03777306: The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07599306: Effectiveness of a Structured Multidimensional Tele-rehabilitation Intervention in Cardiac Patients With Post-Intensive Care Syndrome (CARDIO-PICS)

Sponsor: Fondazione Don Carlo Gnocchi Onlus. Phase: NA. Conditions: Critical Illness, Post Intensive Care Syndrome (PICS), Cardiopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01176006: Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: DOCK8 Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07136584: SOS for Caregiver Wellbeing

Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Mental Health, Depression and Burden in Caregivers, Anxiety Depression, Stress, Caregiver Anxiety, Parent of Child With Chronic Life-threatening Illness

full page →ctgov ↗
›RECRUITINGphase readoutNCT04375384: Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Sponsor: Wake Forest University Health Sciences. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04459884: Multicenter Observational Study on Practice of Ventilation in Brain Injured Patients

Sponsor: University of Milano Bicocca. Phase: . Conditions: Mechanical Ventilation, Acute Brain Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07438938: Measurement of Airway Opening Index During Out-of-hospital Cardiac Arrest: The Lazarus AOI Trial.

Sponsor: University Hospital, Ghent. Phase: . Conditions: Cardiac Arrest (CA), Out-of-hospital Cardiac Arrest (OHCA), Resuscitated Sudden Cardiac Death

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07347938: A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury

Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd.. Phase: . Conditions: Tetanus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07619638: AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis

Sponsor: ENBIOSIS BIOTECHNOLOGIES. Phase: NA. Conditions: Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD), Colitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07412938: JKN2306 in Healthy Subjects: Single Ascending Dose and Food Effect Study

Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd. Phase: PHASE1. Conditions: Acute Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07455149: An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines With Metabolic Dysfunction-associated Fatty Liver Disease

Sponsor: Zhujiang Hospital. Phase: . Conditions: Metabolic Dysfunction-associated Fatty Liver Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT00980538: TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants

Sponsor: Janssen Sciences Ireland UC. Phase: PHASE3. Conditions: HIV Infections, HIV-1

full page →ctgov ↗
›COMPLETEDphase readoutNCT03229538: STeroids to REduce Systemic Inflammation After Infant Heart Surgery

Sponsor: Kevin Hill. Phase: PHASE3. Conditions: Congenital Heart Disease in Children, Inflammatory Response

full page →ctgov ↗
›RECRUITINGphase readoutNCT06301438: Dalpiciclib in HR+/HER2- ABC

Sponsor: RenJi Hospital. Phase: . Conditions: Advanced Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06896838: Comparison of Intercostal and Quadriceps Femoris Muscle Oxygenation in Women and Men

Sponsor: Kirsehir Ahi Evran Universitesi. Phase: . Conditions: Near-Infrared Spectroscopy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07032038: First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant

Sponsor: Rinri Therapeutics. Phase: PHASE1. Conditions: Sensorineural Hearing Loss, Presbyacusis, Auditory Neuropathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07255638: A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Sponsor: Blueprint Medicines Corporation. Phase: . Conditions: Indolent Systemic Mastocytosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06671938: Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

Sponsor: BioArctic AB. Phase: PHASE2. Conditions: Parkinson Disease, Multiple System Atrophy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06682858: Developing a Novel Therapy for Aversive Sensory Experiences in Autism

Sponsor: King's College London. Phase: NA. Conditions: Autism, Autism in Children

full page →ctgov ↗
›RECRUITINGphase readoutNCT07551258: Innate Immune Immunoparalysis and Ventilator-Associated Pneumonia in Critically Ill Elderly Patients

Sponsor: Hospital Universitari de Bellvitge. Phase: . Conditions: Intubated ICU Patients, Ventilator Associated Pneumonia ( VAP), Immunoparalysis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04969926: Natural History Study of Parathyroid Disorders

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Parathyroid Cancer, Primary Hyperparathyroidism, Pseudohypoparathyroidism, Inheritable Bone Diseases, Multiple Endocrine Neoplasia, Type 1

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07575126: Comparison of Qigong and Otago in Patient With Diabetic Neuropathy

Sponsor: Riphah International University. Phase: NA. Conditions: Diabetic Neuropathies

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06194799: ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

Sponsor: ACADIA Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Alzheimer's Disease Psychosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07339098: Efficacy and Safety of the Ultrasound Stimulation Device NEFRONIX in Patients With Chronic Kidney Disease

Sponsor: Anasonic. Phase: NA. Conditions: Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06906263: Complications Related to the Anaesthesia During Airway Endoscopy in Children With Tracheostomy.

Sponsor: Karolinska Institutet. Phase: . Conditions: Anesthesia Complication, Tracheostomy Complications, Children Receiving General Anesthesia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00457587: Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma

Sponsor: University of Wuerzburg. Phase: . Conditions: Adrenocortical Carcinoma, Cushing's Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT03713593: Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Carcinoma, Hepatocellular

full page →ctgov ↗
›COMPLETEDphase readoutNCT02281916: Safety Study of P28GST Treatment in Crohn's Disease Patients

Sponsor: University Hospital, Lille. Phase: PHASE2. Conditions: Crohn's Ileocolitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT02821806: Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Healthy Volunteer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07564206: Foam Roller Compared to Massage on Reducing Calf Muscle Tone in Healthy Subjects

Sponsor: Universidad Europea de Madrid. Phase: NA. Conditions: Muscle Tone, Healthy Adult

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07596004: COMPARISON OF DEXMEDETOMIDINE AND NORMAL SALINE IN NEBULIZATION TO BLUNT HEMODYNAMIC RESPONSE

Sponsor: Shaheed Mohtarma Benazir Bhutto Institue of Trauma. Phase: NA. Conditions: HEMODYNAMIC RESPONSETO LYRANGOSCOPY AND ENDOTRACHEAL INTUBATION

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06118333: A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Nasopharyngeal Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06740084: African Youth in Mind (Y-MIND) - Pilot Feasibility Trial of a Brief Psychological Intervention for Older Adolescents With Depression Delivered Through Senior High Schools in Navrongo, Ghana

Sponsor: King's College London. Phase: NA. Conditions: Depression Disorders

full page →ctgov ↗
›TERMINATEDphase readoutNCT05983133: A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

Sponsor: Seagen, a wholly owned subsidiary of Pfizer. Phase: PHASE1. Conditions: Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06154252: RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Sponsor: Cabaletta Bio. Phase: PHASE2. Conditions: Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome, Immune-Mediated Necrotizing Myopathy, Juvenile Dermatomyositis, Juvenile Polymyositis, Juvenile Idiopathic Inflammatory Myopathy (JIIM), Juvenile Myositis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04009447: Sleep Quality and Mechanisms of Cardiovascular Risks in Adults With Hypertension

Sponsor: Duke University. Phase: NA. Conditions: Hypertension, Insomnia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07519447: Gastric Residual Volume and Aspiration Risk Following Intravenous Metoclopramide in Fasted Diabetic Patients Undergoing Elective Surgery

Sponsor: Kafrelsheikh University. Phase: . Conditions: Gastric Residual Volume, Aspiration Risk, Metoclopramide, Fasted Diabetic Patients, Elective Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT07509749: Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)

Sponsor: Daihong Liu. Phase: PHASE2. Conditions: GVHD, Acute, Stem Cell Transplant Complications

full page →ctgov ↗
← prev
page 55 of 107
next →